<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yonsei Med J</journal-id>
      <journal-id journal-id-type="publisher-id">YMJ</journal-id>
      <journal-title-group>
        <journal-title>Yonsei Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0513-5796</issn>
      <issn pub-type="epub">1976-2437</issn>
      <publisher>
        <publisher-name>Yonsei University College of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21319362</article-id>
      <article-id pub-id-type="pmc">3051216</article-id>
      <article-id pub-id-type="doi">10.3349/ymj.2011.52.2.369</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group>
            <subject>Genetics</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hereditary Spherocytosis Coexisting with UDP-Glucuronosyltransferase Deficiency Highly Suggestive of Crigler-Najjar Syndrome Type II</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Iijima</surname>
            <given-names>Shigeo</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ohzeki</surname>
            <given-names>Takehiko</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maruo</surname>
            <given-names>Yoshihiro</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.</aff>
      <aff id="A2"><label>2</label>Department of Pediatrics, Shiga University Medical Science, Otsu, Japan.</aff>
      <author-notes>
        <corresp>
Corresponding author: Dr. Shigeo Iijima, Department of Neonatology, Toho University School of Medicine, 6-11-1 Omori-nishi, Ota-ku, Tokyo 143-8541, Japan. Tel: 81-3-3762-4151, Fax: 81-3-3762-9376, <email>sige_pd@yahoo.co.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>1</month>
        <year>2011</year>
      </pub-date>
      <volume>52</volume>
      <issue>2</issue>
      <fpage>369</fpage>
      <lpage>372</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>5</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>07</day>
          <month>7</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>7</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Copyright: Yonsei University College of Medicine 2011</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Patients with co-existing hereditary spherocytosis (HS) and UDP-glucuronosyltransferase 1A1 (UGT1A1) deficiency as Gilbert's syndrome (GS) have been reported, and previous studies have demonstrated an increased risk for developing gallstones in patients with co-inheritance of GS and HS. We experienced an interesting case of HS showing persistent jaundice after splenectomy, and upon further evaluation, the 25-year-old female patient was found to have HS combined with UGT1A1 deficiency. Sequence analysis of the UGT1A1 gene revealed that she was a compound heterozygote with p.[G71R; Y486D] + [Y486D] mutations, which suggests Crigler-Najjar syndrome type II rather than GS. Careful evaluation of inappropriately elevated bilirubin level compared with the degree of hemolysis is important, reflecting the therapeutic implication of splenectomy and cholecystectomy.</p>
      </abstract>
      <kwd-group>
        <kwd>Hereditary spherocytosis</kwd>
        <kwd>unconjugated hyperbilirubinemia</kwd>
        <kwd>UDP-glucuronosyltransferase</kwd>
        <kwd>Crigler-Najjar syndrome</kwd>
        <kwd>splenectomy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Hereditary spherocytosis (HS) is the most common cause of hemolytic anemia due to constitutional erythrocyte membrane disorder. Most patients have well-compensated hemolysis but have icterus and cholelithiasis due to chronic hemolysis.<xref ref-type="bibr" rid="B1">1</xref> Familial non-hemolytic unconjugated hyperbilirubinemia including Crigler-Najjar syndrome type I, Crigler-Najjar syndrome type II (CN-II), and Gilbert's syndrome (GS), is associated with a defect in isoenzyme 1A1 of UDP-glucuronosyltransferase (UGT1A1).<xref ref-type="bibr" rid="B2">2</xref> Cases with co-existence of HS and UGT1A1 deficiency as GS have been reported,<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref> and previous studies have demonstrated an increased risk for developing gallstones in patients with co-inheritance of HS and GS.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref> However, there are no reports on HS coexisting with other deficiency state of UGT1A1.</p>
    </sec>
    <sec sec-type="cases">
      <title>CASE REPORT</title>
      <p>The patient was a 25-year-old Japanese woman who had a history of jaundice for 11 years. Her family history revealed that her father had mild jaundice while other family members had normal serum bilirubin levels. The patient received regular medical treatment at a psychiatric outpatient clinic because of truancy. She had been referred to our hospital for extensive evaluation of jaundice at the age of 14 years. Her first blood examination revealed a normal hemoglobin level (12.6 g/dL), slightly elevated reticulocyte count (89 &#xD7; 10<sup>6</sup> /L: reference range, 40 to 80 &#xD7; 10<sup>6</sup> /L), and unconjugated hyperbilirubinemia (serum total bilirubin 113 &#xB5;mol/L) without elevation of liver-associated enzymes. A diagnosis of HS was made based on clinical features including chemical (haptoglobin &lt; 1.0 &#xB5;mol/L) and hematologic findings (spherocytes on blood smear and increased red cell osmotic fragility). However, biochemical analysis of the red cell membrane proteins indicated no significant deficiency. Thereafter, she persistently demonstrated mild jaundice but not anemia. At the age of 16 years, she underwent splenectomy to prevent the formation of gallstones and to reduce skin itching which was probably induced by jaundice. Subsequently, the reticulocyte count decreased and the serum haptoglobin level normalized. However, she was persistently positive for serum bilirubin, which ranged between 86 and 103 &#xB5;mol/L, and it was not clear whether her serum bilirubin level improved after splenectomy. Therefore, we suspected somatic hyperbilirubinemia and carried out further examinations. Physical examination was remarkable only for icteric sclera. Extensive laboratory evaluation revealed normal levels of liver-associated enzymes and lactate dehydrogenase (LDH). The haptoglobin level was 6.0 &#xB5;mol/L with a total bilirubin of 102 and unconjugated fraction of 100 &#xB5;mol/L. A complete blood count revealed normal numbers of white blood cells and platelets with a hemoglobin level of 12.4 g/dL. The corrected reticulocyte count was 34 &#xD7; 10<sup>6</sup>/L. A peripheral blood smear revealed spherocytes. Incubated osmotic fragility was slightly increased. Sequence analysis of the UGT1A1 gene revealed that the patient was heterozygous for a missense mutation (c.211G &gt; A: p.G71R in exon 1) and homozygous for a point mutation (c.1456T &gt; G: p.Y486D in exon 5); that is, she was a compound heterozygote with the p.[G71R; Y486D] + [Y486D] mutations (<xref ref-type="fig" rid="F1">Fig. 1</xref>). As for the parents of the patient, detailed laboratory data could not be obtained, and neither a molecular study of their UGT1A1 gene nor analysis of their erythrocyte membrane proteins was performed.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>According to the diagnostic criteria of HS,<xref ref-type="bibr" rid="B1">1</xref> patients with no anemia and mild reticulocytosis are classified as having the mild type (hemoglobin level from 11 to 15 g/dL, reticulocyte count from 3% to 6%, total bilirubin level from 17 to 34 mg/dL). In contrast, patients with higher bilirubin levels are classified as having either the moderate type (total bilirubin level from 34 to 51 mg/dL) or the severe type (more than 51 mg/dL). Although our patient had mild HS with normal hemoglobin and slightly elevated reticulocyte count, she had an extremely high bilirubin level. This discrepancy suggested other conditions associated with unconjugated hyperbilirubinemia, especially inherited deficiency of hepatic glucuronosyltransferase. In such cases, further evaluation should be performed. Similar cases of coexisting HS and GS have been reported.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B8">8</xref> Since the prevalence of GS in the general population is 5-7%<xref ref-type="bibr" rid="B9">9</xref> and that of HS is one per 2000, the calculated rate of co-occurrence of these two disorders is approximately 25-35 per one million births. In contrast, the incidence of CN-II is one per one million births.<xref ref-type="bibr" rid="B10">10</xref> Therefore, the calculated rate of co-occurrence of HS and CN-II indicates that it is extremely rare.</p>
      <p>Similar to GS, the method of choice for diagnosis of Crigler-Najjar syndrome is mutation analysis of genomic DNA. The phenotype of CN-II is usually associated with homozygosity or compound heterozygosity for missense mutations in the UGT1A1 gene that do not completely inactivate the protein.<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref> Our patient was a compound heterozygote with the p.[G71R; Y486D] allele and p.Y486D allele. However, most Japanese cases with CN-II have been caused by a homozygous double missense mutation (p.[G71R; Y486D] + [G71R; Y486D]),<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref> and the mutation found in our case has not been reported as a cause of CN-II.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B15">15</xref> According to a previous expression study, the relative UGT1A1 activity of a single homozygous model of p.G71R was approximately 30% of normal, that of a single homozygous model of p.Y486D was 7% to 8%, and that of a double homozygous model of p.[G71R; Y486D] + [G71R; Y486D] was 4% to 7%.<xref ref-type="bibr" rid="B14">14</xref> It has been reported that hepatic UGT1A1 activity (measured from liver tissue) in patients with CN-II is less than 10% of normal, whereas that in patients with GS is about 30% of normal.<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref> We concluded that the persistent hyperbilirubinemia after splenectomy in our patient was due to CN-II rather than GS, based on findings from sequence analysis of the UGT1A1 gene.</p>
      <p>When cholelithiasis is present, prophylactic cholecystectomy is performed at the same surgical setting as splenectomy in patients with mild HS.<xref ref-type="bibr" rid="B18">18</xref> However, combined prophylactic splenectomy and cholecystectomy are not recommended for patients with HS with no evidence of cholelithiasis, because it is thought that individuals with HS do not develop pigment stones once the spleen is removed.<xref ref-type="bibr" rid="B19">19</xref> A patient with HS who coinherited GS, has an almost 5-fold greater tendency to form gallstones than a normal HS patient.<xref ref-type="bibr" rid="B6">6</xref> Coexistence with CN-II might further increase the risk of gallstone formation. Therefore, in cases of HS combined with reduced hepatic bilirubin conjugation, it is unknown whether splenectomy alone can sufficiently reduce hemolysis and prevent subsequent gallstone formation. Combined prophylactic splenectomy and cholecystectomy might be recommended for cases like ours. Careful evaluation of inappropriately high serum bilirubin level compared with the degree of hemolysis as defined in the diagnostic criteria of HS<xref ref-type="bibr" rid="B1">1</xref> is important, reflecting the therapeutic implication of splenectomy and cholecystectomy.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>The authors have no financial conflicts of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bolton-Maggs</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Dodd</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Lamont</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tittensor</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <collab>General Haematology Task Force of the British Committee for Standards in Haematology</collab>
          <article-title>Guidelines for the diagnosis and management of hereditary spherocytosis</article-title>
          <source>Br J Haematol</source>
          <year>2004</year>
          <volume>126</volume>
          <fpage>455</fpage>
          <lpage>474</lpage>
          <pub-id pub-id-type="pmid">15287938</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kadakol</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Sappal</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Chowdhury</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Chowdhury</surname>
              <given-names>NR</given-names>
            </name>
          </person-group>
          <article-title>Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype</article-title>
          <source>Hum Mutat</source>
          <year>2000</year>
          <volume>16</volume>
          <fpage>297</fpage>
          <lpage>306</lpage>
          <pub-id pub-id-type="pmid">11013440</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maruo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kurosawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tsuchioka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fujiwara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Severe hyperbilirubinemia in a 10-year-old girl with a combined disorder of hereditary spherocytosis and Gilbert syndrome</article-title>
          <source>Pediatr Int</source>
          <year>2007</year>
          <volume>49</volume>
          <fpage>540</fpage>
          <lpage>542</lpage>
          <pub-id pub-id-type="pmid">17587286</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vukelja</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Kadakia</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Gilbert's syndrome co-existing with and masking hereditary spherocytosis</article-title>
          <source>Ann Hematol</source>
          <year>1997</year>
          <volume>74</volume>
          <fpage>287</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">9236515</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garg</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Teckchandani</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hadke</surname>
              <given-names>NS</given-names>
            </name>
          </person-group>
          <article-title>Hereditary spherocytosis coexisting with Gilberts syndrome: a diagnostic dilemma</article-title>
          <source>Singapore Med J</source>
          <year>2008</year>
          <volume>49</volume>
          <fpage>e308</fpage>
          <lpage>e309</lpage>
          <pub-id pub-id-type="pmid">19037536</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>del Giudice</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Perrotta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nobili</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Specchia</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>d'Urzo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Iolascon</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Coinheritance of Gilbert syndrome increase risk for developing gallstones in patients with hereditary spherocytosis</article-title>
          <source>Blood</source>
          <year>1999</year>
          <volume>94</volume>
          <fpage>2259</fpage>
          <lpage>2262</lpage>
          <pub-id pub-id-type="pmid">10498597</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitsiou-Tzeli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kanavakis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tzetis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kavazarakis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Galla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tsezou</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Gilbert's syndrome as a predisposing factor for idiopathic cholelithiasis in children</article-title>
          <source>Haematologica</source>
          <year>2003</year>
          <volume>88</volume>
          <fpage>1193</fpage>
          <lpage>1194</lpage>
          <pub-id pub-id-type="pmid">14555319</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Economou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsatra</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Athanassiou-Metaxa</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Simultaneous presence of Gilbert syndrome and hereditary spherocytosis: interaction in the pathogenesis of hyperbilirubinemia and gallstone formation</article-title>
          <source>Pediatr Hematol Oncol</source>
          <year>2003</year>
          <volume>20</volume>
          <fpage>493</fpage>
          <lpage>495</lpage>
          <pub-id pub-id-type="pmid">14631626</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Owens</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Population studies on Gilbert's syndrome</article-title>
          <source>J Med Genet</source>
          <year>1975</year>
          <volume>12</volume>
          <fpage>152</fpage>
          <lpage>156</lpage>
          <pub-id pub-id-type="pmid">1142378</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosma</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Chowdhury</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gantra</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>de Boer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oosta</surname>
              <given-names>BA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome</article-title>
          <source>N Engl J Med</source>
          <year>1995</year>
          <volume>333</volume>
          <fpage>1171</fpage>
          <lpage>1175</lpage>
          <pub-id pub-id-type="pmid">7565971</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vieira</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saraiva</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cancela</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analysis of the UDP-glucuronosyltransferase gene in Portuguese patients with a clinical diagnosis of Gilbert and Crigler-Najjar syndromes</article-title>
          <source>Blood Cells Mol Dis</source>
          <year>2006</year>
          <volume>36</volume>
          <fpage>91</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">16269258</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seppen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bosma</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Goldhoorn</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Chowdhury</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Chowdhury</surname>
              <given-names>NR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase</article-title>
          <source>J Clin Invest</source>
          <year>1994</year>
          <volume>94</volume>
          <fpage>2385</fpage>
          <lpage>2391</lpage>
          <pub-id pub-id-type="pmid">7989595</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aono</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Keino</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hanada</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sasaoka</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of defect in the genes for bilirubin UDP-glucuronosyl transferase in a patient with Crigler-Najjar syndrome type II</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1993</year>
          <volume>197</volume>
          <fpage>1239</fpage>
          <lpage>1244</lpage>
          <pub-id pub-id-type="pmid">8280139</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fujiyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Doida</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bamba</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II</article-title>
          <source>Biochem Biophys Acta</source>
          <year>1998</year>
          <volume>1406</volume>
          <fpage>267</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="pmid">9630669</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costa</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Hematologically important mutations: bilirubin UDP-glucuronosyltransferase gene mutations in Gilbert and Crigler-Najjar syndromes</article-title>
          <source>Blood Cells Mol Dis</source>
          <year>2006</year>
          <volume>36</volume>
          <fpage>77</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">16386929</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adachi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Hepatic bilirubin-conjugating enzymes of man in the normal state and in liver disease</article-title>
          <source>Gastroenterol Jpn</source>
          <year>1982</year>
          <volume>17</volume>
          <fpage>235</fpage>
          <lpage>240</lpage>
          <pub-id pub-id-type="pmid">6214447</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moghrabi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Boxer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burchell</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2</article-title>
          <source>Genomics</source>
          <year>1993</year>
          <volume>18</volume>
          <fpage>171</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="pmid">8276413</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marchetti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Quaglini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Barosi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios</article-title>
          <source>J Intern Med</source>
          <year>1998</year>
          <volume>244</volume>
          <fpage>217</fpage>
          <lpage>226</lpage>
          <pub-id pub-id-type="pmid">9747744</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sandler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Winkel</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Soper</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The role of prophylactic cholecystectomy during splenectomy in children with hereditary spherocytosis</article-title>
          <source>J Pediatr Surg</source>
          <year>1999</year>
          <volume>34</volume>
          <fpage>1077</fpage>
          <lpage>1078</lpage>
          <pub-id pub-id-type="pmid">10442593</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Nucleotide sequences of the mutated sections of exons 1 and 5 and the promoter region of the gene encoding UDP-glucurono-syltransferase 1A1 (UGT1A1). (A) Nucleotide sequences of the mutated section of exon 1 of the UGT1A1 gene. A missense mutation at nucleotide 211 in exon 1 of the UGT1A1 gene is observed. The substitution of adenine for guanine changed the codon from GGA to AGA, causing arginine to replace glycine at position 71 (p.G71R in the corresponding protein). An arrow shows the mutation. The patient was heterozygous for p.G71R. (B) Nucleotide sequence of the mutated section of exon 5 of the UGT1A1 gene. The arrow shows the mutation. The patient was homozygous for a point mutation at base position 1456 in exon 5. The substitution of guanine for thymine changed the codon from TAC to GAC, causing a tyrosine-to-aspartic acid substitution at position 486 (p.Y486D in the corresponding protein).</p>
      </caption>
      <graphic xlink:href="ymj-52-369-g001"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
